PharmaRoth Labs, Inc. (ROTH)

[MikeKnowsRunners]

Jay, what you are not understanding is that the company value is in the intellectual property rights to Sucanon, plus the value of the public vehicle. The revenues are in the subsidiaries, not the public vehicle. But what investors should keep in mind is that the company has not diluted a single share. This means, they don’t need the money (or any of the subsidiaries), or they would be selling shares. But instead, the float has remained unchanged.

Impressive accumulation as it seems investors have caught on.

GLTA